Publicaciones en las que colabora con MANUEL GUZMÁN PASTOR (43)

2024

  1. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  2. Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling

    Cancers, Vol. 15, Núm. 9

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2018

  1. Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer

    Biochemical Pharmacology, Vol. 157, pp. 285-293

2017

  1. Loss of Cannabinoid CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility

    Cerebral Cortex, Vol. 27, Núm. 11, pp. 5303-5317

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  2. Anticancer mechanisms of cannabinoids

    Current Oncology, Vol. 23, pp. S23-S32

2015

  1. Endocannabinoids and cancer

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 449-472

  2. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  3. Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer

    Journal of the National Cancer Institute, Vol. 107, Núm. 6

  4. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling

    Molecular and Cellular Oncology, Vol. 2, Núm. 3

2014

  1. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling

    Journal of Biological Chemistry, Vol. 289, Núm. 32, pp. 21960-21972

2013

  1. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

    Oncogene, Vol. 32, Núm. 20, pp. 2534-2542

  2. The role of GPR55 in cancer

    endoCANNABINOIDS: Actions at Non-CB1/CB2 Cannabinoid Receptors (Springer New York), pp. 115-133

2012

  1. Cannabinoids: A new hope for breast cancer therapy?

    Cancer Treatment Reviews, Vol. 38, Núm. 7, pp. 911-918

  2. Towards the use of cannabinoids as antitumour agents

    Nature Reviews Cancer, Vol. 12, Núm. 6, pp. 436-444

2011

  1. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9